Northern Trust’s MAIA Biotechnology MAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.6K Buy
52,539
+13,507
+35% +$24.9K ﹤0.01% 4171
2025
Q4
$59.7K Hold
39,032
﹤0.01% 4244
2025
Q3
$60.1K Hold
39,032
﹤0.01% 4249
2025
Q2
$70.3K Hold
39,032
﹤0.01% 4178
2025
Q1
$59.7K Buy
39,032
+6,961
+22% +$12.9K ﹤0.01% 4206
2024
Q4
$63.5K Hold
32,071
﹤0.01% 4232
2024
Q3
$90.1K Hold
32,071
﹤0.01% 4083
2024
Q2
$110K Buy
32,071
+11,798
+58% +$37.2K ﹤0.01% 4029
2024
Q1
$44.6K Hold
20,273
﹤0.01% 4244
2023
Q4
$23.7K Buy
+20,273
New +$32.7K ﹤0.01% 4343

Other funds holding MAIA

Northern Trust's MAIA Position: Q1 2026 in Review

Northern Trust increased its MAIA Biotechnology (MAIA) stake by 35% in Q1 2026, buying an estimated $24.9K and bringing the position to 52,539 shares worth $73.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4171.

Northern Trust first reported a position in MAIA in Q4 2023 and has held it in 10 quarters since. The position peaked at $110K in Q2 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Northern Trust held 52,539 shares of MAIA Biotechnology worth $73.6K as of Q1 2026.
  • Northern Trust bought 13,507 MAIA Biotechnology shares in Q1 2026, an estimated $24.9K.
  • MAIA Biotechnology made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4171 holding.
  • Northern Trust first reported a position in MAIA Biotechnology in Q4 2023 and has held it in 10 quarters since.
  • Northern Trust's MAIA Biotechnology position peaked at $110K in Q2 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.